Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Federal Trade Commission
Dow
Medtronic
Accenture
Healthtrust
Johnson and Johnson
Express Scripts
UBS

Generated: June 22, 2018

DrugPatentWatch Database Preview

SODIUM NITROPRUSSIDE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Sodium Nitroprusside, and when can generic versions of Sodium Nitroprusside launch?

Sodium Nitroprusside is a drug marketed by Abraxis Pharm, Akorn, Amneal Pharms Co, Amphastar Pharms Inc, Baxter Hlthcare, Micro Labs, Mylan Labs Ltd, Namigen Llc, Nexus Pharms, and Teva Parenteral. and is included in ten NDAs.

The generic ingredient in SODIUM NITROPRUSSIDE is sodium nitroprusside. There are one thousand four hundred and twenty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the sodium nitroprusside profile page.
Summary for SODIUM NITROPRUSSIDE
Drug patent expirations by year for SODIUM NITROPRUSSIDE
Pharmacology for SODIUM NITROPRUSSIDE
Drug ClassVasodilator
Physiological EffectVasodilation

US Patents and Regulatory Information for SODIUM NITROPRUSSIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 070031-001 Jan 17, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Labs Ltd SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 210763-001 Apr 17, 2018 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Amphastar Pharms Inc SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 209832-001 Dec 18, 2017 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Namigen Llc SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 207426-001 Dec 8, 2016 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Julphar
McKesson
Cerilliant
Federal Trade Commission
Argus Health
Johnson and Johnson
Harvard Business School
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.